Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1992 1
1993 2
1996 2
2001 1
2002 5
2003 4
2004 2
2005 4
2006 11
2007 12
2008 17
2009 22
2010 18
2011 10
2012 13
2013 11
2014 12
2015 14
2016 13
2017 22
2018 31
2019 22
2020 30
2021 32
2022 35
2023 26
2024 36
2025 35
2026 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.
Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: di gh. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.
Circadian Control of Neutrophils Drives Collateral Perfusion and Stroke Outcome.
Vázquez-Reyes S, García-Culebras A, Di G, De Castro-Millán FJ, Díaz-Benito B, Nieto-Vaquero C, Ruiz-Sanchez A, Merino-Casamayor E, Parra-Pérez C, Moraga A, Core-Barrera C, Calleja P, Dopazo A, Callejas S, Rubio-Ponce A, Aroca-Crevillén A, Sánchez-Cabo F, Pascual El Bobakry S, Torroja C, Esposito E, Lo EH, Ballesteros I, Hidalgo A, Cuartero MI, Lizasoain I, Moro MÁ. Vázquez-Reyes S, et al. Among authors: di g. Circ Res. 2026 Jan 16;138(2):e326438. doi: 10.1161/CIRCRESAHA.125.326438. Epub 2025 Nov 26. Circ Res. 2026. PMID: 41293815 Free PMC article.
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
Liu Y, Gong Y, Zhu XZ, Liu GY, Yu KD, Yang F, Chen L, He M, Hu Z, Chen CM, Cao AY, Li JJ, Hou YF, Di GH, Wu J, Jiang YZ, Fan L, Wang ZH, Shao ZM. Liu Y, et al. Among authors: di gh. BMJ. 2025 Dec 23;391:e085457. doi: 10.1136/bmj-2025-085457. BMJ. 2025. PMID: 41436191 Free PMC article. Clinical Trial.
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
He M, Jiang YZ, Gong Y, Fan L, Liu XY, Liu Y, Tang LC, Mo M, Hou YF, Di GH, Liu GY, Yu KD, Wu J, Yan X, Zeng XH, Fu DY, Song CG, Zhuang ZG, Wu KJ, Wang J, Wang ZH, Shao ZM. He M, et al. Among authors: di gh. BMJ. 2024 Oct 23;387:e079603. doi: 10.1136/bmj-2024-079603. BMJ. 2024. PMID: 39442958 Free PMC article. Clinical Trial.
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial.
Li JJ, Wang ZH, Chen L, Zhang WJ, Ma LXX, Wu J, Liu GY, Hou YF, Yu KD, Di GH, Fan L, Jiang YZ, Jiang SH, Liang QN, Shen Y, Shao ZM. Li JJ, et al. Among authors: di gh. Ann Oncol. 2025 Jun;36(6):651-659. doi: 10.1016/j.annonc.2025.02.011. Epub 2025 Mar 4. Ann Oncol. 2025. PMID: 40049447 Free article. Clinical Trial.
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.
Yu KD, Ye FG, He M, Fan L, Ma D, Mo M, Wu J, Liu GY, Di GH, Zeng XH, He PQ, Wu KJ, Hou YF, Wang J, Wang C, Zhuang ZG, Song CG, Lin XY, Toss A, Ricci F, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: di gh. JAMA Oncol. 2020 Sep 1;6(9):1390-1396. doi: 10.1001/jamaoncol.2020.2965. JAMA Oncol. 2020. PMID: 32789480 Free PMC article. Clinical Trial.
421 results